5 completed, 2 active not recruiting, 2 withdrawn, 1 recruiting. 11 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 5, Active not recruiting 2, Withdrawn 2, Recruiting 1, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Withdrawn 1 |
Follow Blood sample: new trials by email Literature Review of Blood sample trials Research Report on Blood sample
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer quality of life questionnaires, Blood sample, Regorafenib - Metastatic Colorectal Cancer | Phase 2 / Phase 3 | Active not recruiting | Centre Hospitalier Universitaire de Besancon | 446 | 2023-05-09 | 2026-11-04 |
| 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol Blood sample, Urine sample, Saliva sample - Systemic Lupus Erythematosus (SLE) | Phase 3 | Active not recruiting | University Hospital, Brest | 25 | 2022-11-29 | 2026-06-26 |
| Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial AZA capsules, MTX, blood sample - Crohn Disease, Azathioprine | Phase 3 | Recruiting | Centre Hospitalier Universitaire, Amiens | 166 | 2021-08-26 | 2025-05-28 |
| Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49 Meningococcal Polysaccharide (serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Blood sample - Meningococcal Infection (Healthy Volunteers) | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 471 | 2019-10-04 | 2025-09-11 |
| Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012) Blood Sample - Hepatitis B, Pertussis | Phase 3 | Completed | MCM Vaccines B.V. | 754 | 2016-04-26 | 2020-06-09 |
| Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease blood sample - Crohn Disease | Phase 3 | Completed | Hospices Civils de Lyon | 59 | 2011-01-01 | 2025-12-04 |
| Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers Blood sample, JE-CV administered in Study JEC02 - Encephalitis, Japanese Encephalitis | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 596 | 2009-08-07 | 2017-11-29 |
| New Treatment for Donor Sites Application of donor site dressing [scarlet red, Microbial Nanocellulose (NC), or hyaluronan and thrombin (HT)], Blood sample, Biopsy - Burn | Phase 2 / Phase 3 | Withdrawn | The University of Texas Medical Branch, Galveston | 2006-01-01 | 2012-12-11 | |
| Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients loxapine, midazolam, blood sample, patient monitoring - Acute Agitated Patients | Phase 3 | Terminated | University Hospital, Rouen | 120 | 2005-12-01 | 2015-03-11 |
| HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population blood sample - Diabetes Mellitus Type 2, Proliferative Diabetic Retinopathy | Phase 3 | Withdrawn | Asociación para Evitar la Ceguera en México | 2004-09-01 | 2024-06-03 | |
| Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents Blood sample, Radiography - Growth Hormone Deficiency | Phase 3 | Completed | Pfizer | 90 | 2002-04-01 | 2007-07-30 |
Crohn Disease (2) · Burns (1) · Cicatrix (1) · Colorectal Neoplasms (1) · Diabetes Mellitus, Type 2 (1) · Dwarfism, Pituitary (1) · Emergencies (1) · Encephalitis (1) · Encephalitis, Japanese (1) · Hepatitis B (1) · Lupus Erythematosus, Systemic (1) · Meningococcal Infections (1) · Psychomotor Agitation (1) · Whooping Cough (1)
Sanofi Pasteur, a Sanofi Company (2) · Asociación para Evitar la Ceguera en México (1) · Centre Hospitalier Universitaire de Besancon (1) · Centre Hospitalier Universitaire, Amiens (1) · Hospices Civils de Lyon (1) · MCM Vaccines B.V. (1) · Pfizer (1) · The University of Texas Medical Branch, Galveston (1) · University Hospital, Brest (1) · University Hospital, Rouen (1)
France (5) · Mexico (1) · Philippines (1) · Puerto Rico (1) · Thailand (1) · United States (1)
David N Herndon, MD (1) · Fabienne FM Moritz, MD (1) · Hugo Quiroz-Mercado, MD (1)
PMID 26589954, PMID 31689166, PMID 36632042, PMID 39555800
2016 (1)